Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference


Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines, today announced the Company will participate in a fireside chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7th at 1:30 p.m. ET.

The live webcast can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available following the conference.

About Silence Therapeutics

Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet need. Silence's proprietary mRNAi GOLDtm platform can be used to create siRNAs (short interfering RNAs) that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include zerlasiran designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with high levels of lipoprotein(a) and divesiran designed to address rare hematological diseases, including polycythemia vera. Silence also maintains ongoing research and development collaborations with AstraZeneca, Mallinckrodt Pharmaceuticals, and Hansoh Pharma, among others. For more information, please visit https://www.silence-therapeutics.com/.


These press releases may also interest you

at 08:00
DJI's Revolutionary Avinox Drive System Wins Eurobike Award 2024
DJI, the global leader in civilian drones and innovative camera technology, unveiled at Eurobike 2024 the Avinox Drive System, a groundbreaking e-bike drive system poised to redefine the electric mountain bike (eMTB) experience. The Avinox system,...

at 08:00
Greenlane Renewables Extends $26.5 Million Credit Facility
Greenlane Renewables Inc. ("Greenlane" or the "Company") today announced that the Company has extended its $26.5 million standby letter of credit facility (the "Facility") to April 30, 2025. The Facility is secured by a guarantee from Export...

at 07:30
goeasy Ltd. Announces CEO Transition
goeasy Ltd. , ("goeasy" or the "Company"), one of Canada's leading consumer lenders focused on delivering a full suite of financial services to Canadians with non-prime credit, announced today a leadership transition plan, as Jason Mullins will...

at 07:00
J2 Ventures Secures $150 Million in Latest Funding Round to Propel Tech Startups with Civilian and Government Applications
J2 Ventures, a deep tech venture capital fund focused on new technologies that are critical for both the private sector and national security interests of the U.S and its allies, has raised $150 million for its new Argonne Fund. The oversubscribed...

at 07:00
Intellias Cooperates with ZENRIN to Deliver Japan Map Data at Global Scale
Intellias, a global software engineering and consulting company, introduces a new partnership with ZENRIN, a leading Japan map data provider, to develop cutting-edge digital maps enriched with Japan map data tailored for modern car navigation...

at 07:00
/R E P E A T -- Media advisory - Government of Canada to announce supports for the semiconductor industry/
The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will participate in an announcement about support for the manufacturing and commercialization of semiconductors. By focusing on support for this industry, we're...

More news about Science and technology...


News published on and distributed by: